scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.TAAP.2013.02.009 |
P698 | PubMed publication ID | 23454399 |
P2093 | author name string | Thomas Lundh | |
Lars Barregard | |||
Gerd Sallsten | |||
Magnus Akerstrom | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cadmium | Q1091 |
P304 | page(s) | 286-293 | |
P577 | publication date | 2013-02-27 | |
P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
P1476 | title | The relationship between cadmium in kidney and cadmium in urine and blood in an environmentally exposed population | |
P478 | volume | 268 |
Q88221361 | Antimutagenic and antigenotoxic potential of grape juice concentrate in blood and liver of rats exposed to cadmium |
Q36048730 | Assessing urinary flow rate, creatinine, osmolality and other hydration adjustment methods for urinary biomonitoring using NHANES arsenic, iodine, lead and cadmium data |
Q77792718 | Associations between blood cadmium concentration and kidney function in the U.S. population: impact of sex, diabetes and hypertension |
Q39535027 | Associations of Blood Cadmium Levels With Depression and Lower Handgrip Strength in a Community-Dwelling Elderly Population: A Repeated-Measures Panel Study |
Q28393855 | Blood Cadmium Levels and Incident Cardiovascular Events during Follow-up in a Population-Based Cohort of Swedish Adults: The Malmö Diet and Cancer Study |
Q47601919 | Blood cadmium levels associated with short distant metastasis-free survival time in invasive breast cancer |
Q28383914 | Cadmium exposure and cancer mortality in a prospective cohort: the strong heart study |
Q28392725 | Cadmium exposure and clinical cardiovascular disease: a systematic review |
Q35778934 | Cadmium exposure and incidence of heart failure and atrial fibrillation: a population-based prospective cohort study |
Q40626433 | Cadmium exposure and the risk of breast cancer in Chaoshan population of southeast China |
Q38619277 | Cadmium or cadmium compounds and chronic kidney disease in workers and the general population: a systematic review |
Q38367324 | Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment? |
Q36456213 | Confusion about Cadmium Risks: The Unrecognized Limitations of an Extrapolated Paradigm |
Q55260734 | Dietary Cadmium Intake and Its Effects on Kidneys. |
Q35781899 | Dietary Intake Estimates and Urinary Cadmium Levels in Danish Postmenopausal Women |
Q64900719 | Early-Life Cadmium Exposure and Bone-Related Biomarkers: A Longitudinal Study in Children. |
Q37006642 | Effect of Occupational Cadmium Exposure on Parathyroid Gland |
Q64265136 | Exposure profile of mercury, lead, cadmium, arsenic, antimony, copper, selenium and zinc in maternal blood, cord blood and placenta: the Tohoku Study of Child Development in Japan |
Q35144665 | First steps toward harmonized human biomonitoring in Europe: demonstration project to perform human biomonitoring on a European scale |
Q28397320 | Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc |
Q51451706 | Genome wide association study identifies two loci associated with cadmium in erythrocytes among never-smokers. |
Q29248460 | Health Risk Assessment of Dietary Cadmium Intake: Do Current Guidelines Indicate How Much is Safe? |
Q49824548 | Heavy Metal Exposure and Metabolic Syndrome: Evidence from Human and Model System Studies |
Q28392106 | Impact of urine concentration adjustment method on associations between urine metals and estimated glomerular filtration rates (eGFR) in adolescents |
Q57053849 | Is renal tubular cadmium toxicity clinically relevant? |
Q36800110 | Low-Level Cadmium Exposure Is Associated With Decreased Bone Mineral Density and Increased Risk of Incident Fractures in Elderly Men: The MrOS Sweden Study |
Q34607577 | Low-level cadmium exposure and effects on kidney function |
Q52669450 | Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy. |
Q28385446 | Non-renal effects and the risk assessment of environmental cadmium exposure |
Q36801690 | Physiologically-based toxicokinetic model for cadmium using Markov-chain Monte Carlo analysis of concentrations in blood, urine, and kidney cortex from living kidney donors. |
Q50107346 | Protective effect of Potentilla anserina polysaccharide on cadmium-induced nephrotoxicity in vitro and in vivo |
Q91810782 | Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-κB signaling in rats |
Q28073733 | Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic Metals |
Q47621011 | Temporal variability of urinary cadmium in spot urine samples and first morning voids. |
Q55711027 | Urinary Cadmium Threshold to Prevent Kidney Disease Development. |
Q36854269 | Urinary Cadmium and Risk of Invasive Breast Cancer in the Women's Health Initiative. |
Q47744726 | Urinary arsenic, cadmium, manganese, nickel, and vanadium levels of schoolchildren in the vicinity of the industrialised area of Asaluyeh, Iran. |
Q37362085 | Urinary cadmium and estimated dietary cadmium in the Women's Health Initiative. |
Q56834525 | Urinary trace element concentrations in environmental settings: is there a value for systematic creatinine adjustment or do we introduce a bias? |
Q88951655 | Urine and toenail cadmium levels in pregnant women: A reliability study |
Q85719231 | Variability of urinary cadmium excretion in spot urine samples, first morning voids, and 24 h urine in a healthy non-smoking population: implications for study design |
Search more.